Home / Applications / Cosmetics / Lutein Ester Bioproduction Engineering Service

Lutein Ester Bioproduction Engineering Service

Lutein Ester is a highly bioavailable and stable form of the carotenoid Lutein, widely used in dietary supplements (for eye health) and as a natural colorant in the food and cosmetics industries. Traditional production via plant extraction (e.g., marigold petals) suffers from low purity in plant extraction , often yielding a mixture of Lutein, Lutein mono- and di-esters, and other xanthophylls, requiring complex and expensive chromatography for purification. Furthermore, the free Lutein intermediate exhibits poor stability against oxidation, light, and heat. Biosynthesis in an engineered microbial host offers precise control over product composition and enhanced stability.

CD Biosynsis offers a synthetic biology service focused on efficient Lutein Ester production in Escherichia coli. Our core strategy involves modification of carotenoid pathway in Escherichia coli . We genetically engineer the E. coli host by introducing and optimizing the gene cluster (CrtE, CrtB, CrtI, CrtY, CrtX, CrtL, CrtY) necessary to convert endogenous IPP precursors into Lutein. This pathway is meticulously balanced to ensure high flux toward the final Lutein molecule. This is coupled with overexpression of acyltransferase . We introduce and heavily overexpress a specific Lutein Acyltransferase enzyme (LutE or a functional homolog) designed to perform the esterification reaction. This enzyme efficiently converts the newly synthesized free Lutein into the highly stable Lutein diester (the desired form). The overexpression is controlled to maximize conversion, thereby ensuring high purity and superior stability of the final product. This integrated approach aims to deliver a high-titer, high-purity Lutein Ester product from a fast-growing microbial host, eliminating the variability and complexity associated with plant extraction.

Get a Quote
Pain Points Solutions Advantages Process FAQ

Pain Points

Developing a competitive Lutein Ester production route faces these key limitations:

  • Low Purity in Plant Extraction: Marigold extracts contain a complex mixture of pigments and waxes, making it difficult and expensive to isolate the desired Lutein diester at high purity levels.
  • Poor Stability: The free Lutein molecule is highly sensitive to degradation by oxygen, light, and high temperature , leading to significant loss of product potency during manufacturing and storage.
  • Precursor Bottlenecks: E. coli naturally lacks the full Lutein pathway. Simply introducing the genes often results in poor yields due to rate-limiting steps in the MEP (Methylerythritol Phosphate) precursor pathway .
  • Incomplete Esterification: If the acyltransferase is not highly active or sufficiently expressed, the final product will be a mixture of free Lutein, mono-ester, and di-ester , complicating formulation and stability.

A successful solution must ensure microbial synthesis of Lutein and achieve complete enzymatic conversion to the highly stable diester form.

Solutions

CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Lutein Ester production in E. coli:

Modification of Carotenoid Pathway in E. coli

           

We engineer the native MEP precursor pathway and introduce the Lutein synthesis cluster (Crt genes) with balanced gene expression to eliminate bottlenecks and maximize flux to Lutein.

Overexpression of Acyltransferase

We introduce and overexpress a highly active, Lutein-specific Acyltransferase (LutE) to drive the complete, high-efficiency conversion of Lutein to the desired, stable Lutein Diester form.

Metabolite Localization Optimization

We engineer the host cell (e.g., using lipid droplet targeting ) to create an optimal cellular environment for the synthesis and accumulation of the hydrophobic Lutein and Lutein Ester.

By-product Pathway Deletion

We knock out or downregulate genes that lead to the formation of undesired carotenoid by-products (e.g., zeaxanthin) or precursors, ensuring maximum purity of the Lutein Ester.

This systematic approach is focused on rebuilding the entire pathway to ensure high microbial yield and complete product stabilization.

Advantages

Our Lutein Ester engineering service is dedicated to pursuing the following production goals:

High Purity of Lutein Diester

Microbial synthesis ensures a minimal complex mix of related xanthophylls , leading to a product requiring less purification.

Superior Stability and Shelf-life

Enzymatic conversion to the diester form protects the Lutein molecule from oxidation and degradation, solving the poor stability issue.

Controllable Product Composition

Gene expression fine-tuning allows for precise control over the mono-/di-ester ratio , which is impossible with plant extraction.

High Titer from Fast-growing Host

E. coli fermentation cycles are fast and scalable, leading to higher volumetric productivity compared to slow-growing plants.

Cost-Effective Raw Materials

Utilizes inexpensive carbon sources (e.g., glucose) instead of expensive, seasonally dependent plant biomass as feedstock.

We provide a highly controlled, high-yield biosynthetic route for Lutein Ester production.

Process

Our Lutein Ester strain engineering service follows a rigorous, multi-stage research workflow:

  • Precursor Pathway Optimization: Overexpress rate-limiting enzymes in the MEP pathway to maximize IPP and DMAPP precursor supply.
  • Carotenoid Cluster Assembly: Integrate and balance the expression of the Crt genes (from CrtE to CrtY) and hydroxylases required for conversion to Lutein.
  • Acyltransferase Overexpression: Clone and highly overexpress the Lutein Acyltransferase gene under a strong, inducible promoter to ensure fast and complete esterification.
  • Pathway Deletion and Fine-tuning: Knock out competing pathways (e.g., those forming zeaxanthin) and tune expression using ribosome-binding site libraries for optimal flux.
  • Fermentation Performance Validation: Test the final engineered strain in fed-batch fermentation to assess Lutein Ester titer and purity (Lutein diester %).
  • Result Report Output: Compile a detailed Experimental Report including gene modification data, metabolic flux analysis, and fermentation metrics (yield, titer, and esterification rate) , supporting commercial scale-up.

Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and esterification completeness.

Explore the potential for a stable, high-purity Lutein Ester supply. CD Biosynsis provides customized strain and enzyme engineering solutions:

  • Detailed Esterification Profile Report , demonstrating the percentage of Lutein converted to the desired diester form.
  • Consultation on optimized cell disruption and solvent extraction protocols for efficient Lutein Ester recovery from E. coli biomass.
  • Experimental reports include complete raw data on volumetric titer (g/L) and A/Z ratio (Lutein to Zeaxanthin content), essential for quality control.

FAQ (Frequently Asked Questions)

Still have questions?

Contact Us

What is the difference between Lutein and Lutein Ester?

Lutein is the free xanthophyll with two hydroxyl (OH) groups. Lutein Ester is Lutein where one or both OH groups are esterified with fatty acids (mono- or di-ester). The esterified form is less polar and significantly more stable against heat and oxidation.

How does microbial synthesis solve the purity issue?

In E. coli, we only introduce the specific genes needed to make Lutein and the Lutein Ester. This controlled pathway avoids the synthesis of many structurally similar, contaminating pigments (like Zeaxanthin or Cryptoxanthin) that naturally occur in plants, yielding a cleaner product .

What is the MEP pathway bottleneck?

The MEP (Methylerythritol Phosphate) pathway is the native bacterial route for generating IPP and DMAPP precursors. Enzymes in this pathway (e.g., DXS) are often subject to feedback inhibition. Overcoming this inhibition through genetic modification is crucial for driving high Lutein production.

Why use E. coli instead of yeast for this product?

While yeast can be used, E. coli offers faster growth rates and simpler genetics for incorporating the bacterial-origin carotenoid pathway genes. It also allows for easier control of the MEP pathway, often leading to higher initial titers of the precursor.

What is the estimated project timeline?

A project involving multi-gene pathway assembly, MEP optimization, and enzyme overexpression typically requires 20-24 weeks for final strain delivery and comprehensive performance validation.

0

There is no product in your cart.